- Home
- ALMS vs NATH Comparison
ALMS vs NATH Comparison
Compare ALMS & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALMS
- NATH
- Stock Information
- Founded
- ALMS 2021
- NATH 1916
- Country
- ALMS United States
- NATH United States
- Employees
- ALMS N/A
- NATH N/A
- Industry
- ALMS
- NATH Restaurants
- Sector
- ALMS
- NATH Consumer Discretionary
- Exchange
- ALMS NYSE
- NATH Nasdaq
- Market Cap
- ALMS 402.6M
- NATH 398.3M
- IPO Year
- ALMS 2024
- NATH N/A
- Fundamental
- Price
- ALMS $4.13
- NATH $94.85
- Analyst Decision
- ALMS Strong Buy
- NATH
- Analyst Count
- ALMS 6
- NATH 0
- Target Price
- ALMS $19.80
- NATH N/A
- AVG Volume (30 Days)
- ALMS 686.1K
- NATH 69.2K
- Earning Date
- ALMS 08-12-2025
- NATH 08-11-2025
- Dividend Yield
- ALMS N/A
- NATH 2.11%
- EPS Growth
- ALMS N/A
- NATH 22.29
- EPS
- ALMS N/A
- NATH 5.87
- Revenue
- ALMS $17,389,000.00
- NATH $148,182,000.00
- Revenue This Year
- ALMS N/A
- NATH N/A
- Revenue Next Year
- ALMS N/A
- NATH N/A
- P/E Ratio
- ALMS N/A
- NATH $16.16
- Revenue Growth
- ALMS N/A
- NATH 6.91
- 52 Week Low
- ALMS $2.76
- NATH $69.07
- 52 Week High
- ALMS $13.11
- NATH $118.50
- Technical
- Relative Strength Index (RSI)
- ALMS N/A
- NATH 34.11
- Support Level
- ALMS N/A
- NATH $93.82
- Resistance Level
- ALMS N/A
- NATH $99.22
- Average True Range (ATR)
- ALMS 0.00
- NATH 3.46
- MACD
- ALMS 0.00
- NATH -0.70
- Stochastic Oscillator
- ALMS 0.00
- NATH 5.57
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.